ZD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ziff Davis Inc (ZD) does not present a compelling buy opportunity for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While there are some positive developments, such as hedge fund buying and a bullish moving average trend, the company's weak financial performance, negative news sentiment, and lack of strong proprietary trading signals suggest caution. Holding off on investment until further clarity on financial health and operational stability is recommended.
The stock's technical indicators are mixed. The MACD is below zero and negatively contracting, signaling bearish momentum. RSI is neutral at 65.407, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Support and resistance levels indicate the stock is trading near its pivot point of 42.901, with resistance at 44.631 and support at 41.17.
Hedge funds are significantly increasing their positions in ZD, with a 319.04% rise in buying activity last quarter. Additionally, the company's decision to sell its Connectivity division for $1.2B could unlock value and provide a catalyst for future growth.
The company's Q4 2025 financials show significant declines in revenue (-1.48% YoY), net income (-99.42% YoY), and EPS (-99.33% YoY). Negative news sentiment, including investigations into financial transparency and missed earnings expectations, further erodes investor confidence. Analysts have also lowered price targets due to weak performance in the Technology & Shopping segment.
In Q4 2025, Ziff Davis reported revenue of $406.7 million (-1.48% YoY), net income of $370,000 (-99.42% YoY), and EPS of $0.01 (-99.33% YoY). Gross margin improved to 71.68% (+92.79% YoY), but this was overshadowed by significant declines in profitability and earnings.
Analyst sentiment is neutral overall. Recent price target changes include Citi raising its target to $48 from $29, Barclays raising its target to $45 from $34, and Evercore ISI lowering its target to $46 from $62. Analysts acknowledge potential value in the stock but highlight concerns about financial transparency, weak performance in key segments, and uncertain rerating catalysts.
